| α-TAT | α-tubulin acetyltranferase |
| ABP | Actin binding protein |
| ADC | Antibody-drug conjugate |
| AML | Acute myeloid leukemia |
| ATM | Ataxia Telangiectasia Mutated |
| BER | Base excision repair |
| CSC | Cancer stem cells |
| CTL | Cytotoxic T-cells |
| DDR | DNA damage response |
| DSB | Double stranded break |
| dsbNETs | DSB-capturing nuclear envelope tubules |
| ECM | Extracellular matrix |
| EMT | Epithelial-mesenchymal transition |
| HNPCC | Hereditary non-polyposis colorectal cancer |
| HNSCC | Head and neck squamous cell carcinoma |
| HR | Homologous recombination |
| ICL | Interstrand cross-links |
| IF | Intermediate filaments |
| JMY | Junction-mediating and regulatory protein |
| LINC | Linker of nucleoskeleton and cytoskeleton |
| MAP | Microtubule-associated proteins |
| MET | Mesenchymal-epithelial transition |
| MMR | Mismatch repair |
| MRN | MRE11/RAD50/NBS1 complex |
| MTA | Microtubule targeting agent |
| MTBP | Microtubules binding protein |
| MTOC | Microtubule organising centre |
| NER | Nucleotide excision repair |
| NHEJ | Non-homologous end joining |
| NK cell | Natural killer cell |
| NSCLC | Non-small cell lung cancer |
| OGG1 | Oxoguanine glycosylase 1 |
| PCNA | Proliferating cell nuclear antigen |
| PTM | Post-translational modification |
| ROS | Reactive oxygen species |
| RPA | Replication protein A |
| SSB | Single strand break |
| TLS | Translesion synthesis |